RxSight Inc Forecast, price target & analysts
RxSight Inc Target price 2026 - Analyst rating & recommendation
RxSight Inc Classifications & Recommendation
RxSight Inc Price Target
| Target Price | $7.14 |
| Price | $5.20 |
| Potential |
37.31%
register free of charge
|
| Number of Estimates | 10 |
|
10 Analysts have issued a price target RxSight Inc 2027 .
The average RxSight Inc target price is $7.14.
This is
37.31%
register free of charge
$11.55
122.12%
register free of charge
$6.36
22.37%
register free of charge
|
|
| A rating was issued by 15 analysts: 1 Analysts recommend RxSight Inc to buy, 9 to hold and 5 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the RxSight Inc stock has an average upside potential 2027 of
37.31%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 134.48 | 149.90 |
| 3.89% | 11.47% | |
| EBITDA Margin | -35.81% | -28.95% |
| 36.14% | 19.16% | |
| Net Margin | -28.96% | -26.48% |
| 47.55% | 8.55% |
12 Analysts have issued a sales forecast RxSight Inc 2026 . The average RxSight Inc sales estimate is
This results in the following potential growth metrics:
9 Analysts have issued an RxSight Inc EBITDA forecast 2026. The average RxSight Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
12 RxSight Inc Analysts have issued a net profit forecast 2026. The average RxSight Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.95 | -0.95 |
| 33.80% | 0.00% | |
| P/E | negative | |
| EV/Sales | 0.05 |
12 Analysts have issued a RxSight Inc forecast for earnings per share. The average RxSight Inc EPS is
This results in the following potential growth metrics and future valuations:
Current RxSight Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Stifel |
Locked
➜
Locked
|
Locked | Aug 10 2026 |
| UBS |
Locked
➜
Locked
|
Locked | Aug 06 2026 |
| B of A Securities |
Locked
➜
Locked
|
Locked | Jul 07 2026 |
| Needham |
Locked
➜
Locked
|
Locked | Jul 07 2026 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | May 07 2026 |
| Needham |
Locked
➜
Locked
|
Locked | May 07 2026 |
| Stifel |
Locked
➜
Locked
|
Locked | Mar 09 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Stifel:
Locked
➜
Locked
|
Aug 10 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
Aug 06 2026 |
|
Locked
B of A Securities:
Locked
➜
Locked
|
Jul 07 2026 |
|
Locked
Needham:
Locked
➜
Locked
|
Jul 07 2026 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
May 07 2026 |
|
Locked
Needham:
Locked
➜
Locked
|
May 07 2026 |
|
Locked
Stifel:
Locked
➜
Locked
|
Mar 09 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
